TIDMEAH

19 December 2017

ECO Animal Health Group plc

(AIM: EAH)

ECO RECEIVES MARKETING AUTHORISATION FOR AIVLOSIN® FOR CHICKENS LAYING EGGS FOR HUMAN CONSUMPTIONIN THE PHILIPPINES

ECO Animal Health Group plc (the "Group") is pleased to announce that its subsidiary ECO Animal Health Limited (ECO) has received a marketing authorisation from the Animal Feeds, Veterinary Drugs and Biologics Control Division of the Bureau of Animal Industry of the Department of Agriculture in the Republic of the Philippines for the use of Aivlosin® 625 mg/g water soluble granules in chickens laying eggs for human consumption.

This approval allows ECO to start selling Aivlosin® in the Philippines for the medication of drinking water for the treatment of infections caused by Mycoplasma in poultry laying eggs for human consumption, with a zero day drug withdrawal period for eggs.

ECO has begun the process of submitting the EU approved Aivlosin® regulatory files for the treatment of layers in numerous other key egg producing markets.

Aivlosin ® , ECO's patented antimicrobial, is used under veterinary prescription for the treatment of a variety of economically important respiratory and enteric (gut) diseases in poultry and pigs.

Peter Lawrence, Chairman of ECO, commented "The Philippines is the fourth most important egg producing country in South East Asia and is ranked seventeenth globally for commercial layers. This latest approval demonstrates ECO's continued progress towards becoming a major force in the international market for veterinary pharmaceutical products for livestock."

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR").Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

Contacts:

ECO Animal Health Group plc

 
Peter Lawrence                                 020 8336 6190 
Marc Loomes                                    020 8447 6906 
Spiro Financial 
Anthony Spiro                                  020 8336 6196 
Peel Hunt LLP (Nominated Adviser) 
Dan Webster, Adrian Trimmings, George Sellar   020 7418 8900 
N+1 Singer (Joint Broker)                      020 7496 3000 
Mark Taylor, Brough Ransom

ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for animals. Our products for these global growth markets promote well-being. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders

View source version on businesswire.com:http://www.businesswire.com/news/home/20171218005815/en/

 
This information is provided by Business Wire

(END) Dow Jones Newswires

December 19, 2017 02:00 ET (07:00 GMT)

Eco Animal Health (LSE:EAH)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Eco Animal Health Charts.
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Eco Animal Health Charts.